A1 Refereed original research article in a scientific journal

Men with Crohn's disease may have an increased risk for head and neck squamous cell carcinoma - a nationwide register study




AuthorsHarjunen Anni, Puolakkainen Enna, Laine Hanna K, Rautava Jaana

PublisherSPRINGER HEIDELBERG

Publication year2023

Journal: Clinical Oral Investigations

Journal name in sourceCLINICAL ORAL INVESTIGATIONS

Journal acronymCLIN ORAL INVEST

Number of pages6

ISSN1432-6981

eISSN1436-3771

DOIhttps://doi.org/10.1007/s00784-022-04762-w

Publication's open availability at the time of reportingOpen Access

Publication channel's open availability Partially Open Access publication channel

Web address https://doi.org/10.1007/s00784-022-04762-w

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/177335906


Abstract

Objective Our goal was to study inflammatory bowel disease (IBD) patients' risk of head and neck squamous cell carcinoma (HNSCC), compared to general population.

Materials and methods We performed a retrospective nationwide register-based study of Finnish individuals diagnosed with IBD between the years 1995 and 2015. The standardized incidence ratio (SIR) of HNSCC was calculated by comparing the cohort's complementary age-year-sex-person-year incidence to that of the whole Finnish population.

Results About 70,567 patients were diagnosed with IBD (Crohn's disease or ulcerative colitis). Later, 89 of them were diagnosed with HNSCC with mean time of 6.82 years. The incidence of HNSCC was increased in IBD patients compared to the Finnish population expectation (SIR 1.3, 95% CI 1.065-1.614, P = 0.062). When calculating Crohn's disease and ulcerative colitis separately as well as men and women separately, the incidence was particularly increased for men with Crohn's disease (SIR 1.951, 95% CI 1.216-2.935, P = 0.025).

Conclusion An increased risk for HNSCC was found in men with Crohn's disease compared to the Finnish population expectations.

Clinical relevance This study provides information that would improve follow-up protocols and treatment guidelines of IBD.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 26/11/2024 10:43:33 PM